id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-335104-8b2tpbsh	Carugno, Andrea	Coronavirus disease 2019 (COVID‐19) rash in a psoriatic patient treated with Secukinumab: Is there a role for Interleukin 17?	2020-07-27		.txt	text/plain	589	47	60	authors: Carugno, Andrea; Gambini, Daniele Mario; Raponi, Francesca; Vezzoli, Pamela; Robustelli Test, Elisa; Arosio, Marco Enrico Giovanni; Callegaro, Annapaola; Sena, Paolo title: Coronavirus disease 2019 (COVID‐19) rash in a psoriatic patient treated with Secukinumab: Is there a role for Interleukin 17? Various cutaneous manifestations have been observed in COVID-19 patients 1 and there has been worldwide concern among patients undergoing biologic therapies. [2] [3] [4] We report our experience with a COVID-19 psoriatic patient treated with anti-interleukin-(IL)-17 who developed a late onset rash. About 5 weeks later, he referred to us due to the rapid onset of a mild pruritic erythematooedematous morbilliform rash, rapidly spreading from arms to trunk and lower limbs; he also showed an initial flare-up of his psoriasis The patient developed a mild form of COVID-19, even though his age and comorbidities are most typically associated with poorer prognosis. Novel coronavirus disease (COVID-19) and biologic therapy in psoriasis: infection risk and patient counseling in uncertain times	./cache/cord-335104-8b2tpbsh.txt	./txt/cord-335104-8b2tpbsh.txt